DAILY FDA RECALL INFORMATION · INFORMACIÓN DIARIA

Medication recalls, NDCs and lot information.

This page requests the newest drug-enforcement reports directly from the official FDA openFDA service whenever it is opened. NDC numbers appear only when FDA included them in the product description. Lot, batch and expiration information is reproduced from FDA’s code-information field.

●Checked August 22, 2026 at 12:15 PM ET
Do not stop a medication based only on this page.Compare the exact medication name, NDC, lot/batch and expiration with the original FDA notice. Contact the dispensing pharmacy, manufacturer, veterinarian or appropriate licensed clinician for product-specific instructions. For urgent symptoms or emergencies, contact emergency services.

HUMAN MEDICATIONS

Latest FDA drug recall reports

30 reports shown
Class IID-0733-2026

Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

NDC59651-719-99

Lot / batch / code informationBatch # DMC125018A, Exp Date: 07/2027.

Recalling companyAurobindo Pharma USA Inc

Recall initiated07/23/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: shortfill; reports of empty capsules.

Distribution: US Nationwide.

Class ID-0744-2026

Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1

NDC81298-8114-1

Lot / batch / code informationLot # V24010V1, Exp 3/31/2027

Recalling companySunny Pharmtech Inc.

Recall initiated07/17/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Presence of Particulate Matter; identified as stainless steel

Distribution: USA Nationwide

Class IIID-0740-2026

Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Inc., Atlanta, 1750 Corp Dr. Ste 725, Norcross, GA 30093 (844) 903-6418

NDCNot listed in FDA product description

Lot / batch / code informationLot #: 20-1535990-0-1 & 20-1535892-0-1, Exp. Date 16 July 2026

Recalling companyCentral Admixture Pharmacy Services Inc

Recall initiated07/16/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Incorrect Product Formulation

Distribution: GA only

Class IID-0745-2026

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.

NDC70710-1159-3

Lot / batch / code informationLot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3

Recalling companyZydus Pharmaceuticals (USA) Inc

Recall initiated08/05/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Distribution: Nationwide in the USA

Class ID-0743-2026

Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1

NDC81298-8112-1

Lot / batch / code informationLot # C23019V1, Exp 10/31/2026; C24015V1, Exp 4/30/2027

Recalling companySunny Pharmtech Inc.

Recall initiated07/17/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Presence of Particulate Matter; identified as stainless steel

Distribution: USA Nationwide

Class IIID-0738-2026

Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-68.

NDC0904-7253-68

Lot / batch / code informationLot: 25141585, Exp. April 30, 2027.

Recalling companyAscend Laboratories, LLC

Recall initiated07/16/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

Distribution: USA Nationwide

Class IIID-0739-2026

Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-04.

NDC0904-7253-04

Lot / batch / code informationLot: 25141586, Exp. April 30, 2027.

Recalling companyAscend Laboratories, LLC

Recall initiated07/16/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

Distribution: USA Nationwide

Class IID-0731-2026

Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ 07407, NDC 68462-626-52.

NDC68462-626-52

Lot / batch / code informationLot #: 19260937A, Exp. Date February 2028; 19261225A, 19261185A, Exp. Date March 2028; 19261664A, 19261682A, Exp. Date April 2028.

Recalling companyGlenmark Pharmaceuticals Inc., USA

Recall initiated07/23/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.

Distribution: Nationwide within the United States.

Class IID-0734-2026

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).

NDC67457-386-00, 67457-386-81

Lot / batch / code informationLot #: 3241653, Exp 4/30/2027

Recalling companyMYLAN PHARMACEUTICALS INC

Recall initiated07/02/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Presence of precipitate

Distribution: USA Nationwide

Class IID-0730-2026

Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.

NDC42571-147-26

Lot / batch / code informationLot # DLHU0031, Exp Date: 06/30/2027.

Recalling companyMICRO LABS USA INC

Recall initiated07/22/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.

Distribution: Nationwide in the USA.

Class IIID-0737-2026

Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7255-68.

NDC0904-7255-68

Lot / batch / code informationLot: 25141583, Exp. April 30, 2027.

Recalling companyAscend Laboratories, LLC

Recall initiated07/16/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

Distribution: USA Nationwide

Class IID-0716-2026

Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011012, NDC 10742-8158-1

NDC10742-8158-1

Lot / batch / code informationLot #: 3H2V, 3H3V, Exp. Date 2026/07; 3J1V, 3J3V, 3J4V, 3J5V, Exp. Date 2026/09; 3K1V, 3K2V, Exp. Date 2026/10; 4A2V, Exp. Date 2026/12; 4B1V, 4B2V, 4B3V, Exp. Date 2027/01; 4F1V, 4F2V, 4F2V, 4F3V, 4F4V, Exp. Date 2027/05; 4G2V, 4G3V, 4G4V, 4G5V, Exp. Date 2027/06; 4H1V, Exp. Date 2027/07; 4I1V, 4I2V, 4I4V, 4I5V, Exp. Date 2027/08.

Recalling companyRohto-Mentholatum (Vietnam) Co., Ltd.

Recall initiated07/14/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Lack of Assurance of Sterility

Distribution: Nationwide within the United States

Class IID-0709-2026

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3560-0; NDC Blister: 0904-6951-61

NDC55154-3560-0, 0904-6951-61

Lot / batch / code informationBag lot #: N02172A, N02172B, Exp. Date 07/2026; N02288A, N02288B, Exp. Date 12/2026; Blister lot #: N02172, Exp. Date 07/2026; N02288, Exp. Date 12/2026

Recalling companyMajor Pharmaceuticals

Recall initiated07/13/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Subpotent Drug

Distribution: Nationwide in the USA.

Class IID-0722-2026

Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%), Sterile, 0.4 FL OZ (13 mL) each, Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742010749, NDC 10742-8141-1

NDC10742-8141-1

Lot / batch / code informationLot #: 3J1V, Exp. Date 2026/09; 4A1V, Exp. Date 2026/12; 4G1V, 4G2V, Exp. Date 2027/06; 4I1V, Exp. Date 2027/08; 4JIV, Exp. Date 2027/09; 5A1V, Exp. Date 2027/12 ; 5B1V, Exp. Date 2028/01; 5F1V, Exp. Date 2028/05; 5F1VA, Exp. Date 2028/05; 5H1V & 5H1VA, Exp. Date 2028/07; 5J1V, 5J1VA, Exp. Date 2028/09; 5L1V, Exp. Date 2028/11; 6B1V, Exp. Date 2029/01.

Recalling companyRohto-Mentholatum (Vietnam) Co., Ltd.

Recall initiated07/14/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Lack of Assurance of Sterility

Distribution: Nationwide within the United States

Class IID-0711-2026

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3563-0; NDC Blister: 0904-6956-61

NDC55154-3563-0, 0904-6956-61

Lot / batch / code informationBag lot #: N02167A, Exp. Date 07/2026; Blister lot # N02167, Exp. Date 07/2026

Recalling companyMajor Pharmaceuticals

Recall initiated07/13/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Subpotent Drug

Distribution: Nationwide in the USA.

Class IID-0703-2026

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61

NDC0904-6952-61

Lot / batch / code informationLot #: N02310, Exp. Date 01/2027

Recalling companyMajor Pharmaceuticals

Recall initiated07/13/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Subpotent Drug

Distribution: Nationwide in the USA.

Class IID-0727-2026

Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05

NDC63323-286-23, 63323-286-05

Lot / batch / code informationLot #: 6133436, Exp. Date 10/2028

Recalling companyFresenius Kabi USA, LLC

Recall initiated07/16/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Presence of Particulate Matter: Hair was found in products

Distribution: Nationwide within in the USA

Class IID-0702-2026

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61

NDC0904-6951-61

Lot / batch / code informationLot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026

Recalling companyMajor Pharmaceuticals

Recall initiated07/13/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Subpotent Drug

Distribution: Nationwide in the USA.

Class IID-0710-2026

Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3562-0; NDC Blister: 0904-6951-61

NDC55154-3562-0, 0904-6951-61

Lot / batch / code informationBag lot #: N02266A, N02266B, Exp. Date 11/2026; Blister lot #: N02266, Exp. Date 11/2026

Recalling companyMajor Pharmaceuticals

Recall initiated07/13/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Subpotent Drug

Distribution: Nationwide in the USA.

Class IID-0700-2026

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6949-61

NDC0904-6949-61

Lot / batch / code informationLot#: N02212, Exp. Date 07/2026

Recalling companyMajor Pharmaceuticals

Recall initiated07/13/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Subpotent Drug

Distribution: Nationwide in the USA.

Class IID-0719-2026

Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%), Sterile, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742010602, NDC 10742-8175-1

NDC10742-8175-1

Lot / batch / code informationLot #: 4B1V, 4B1VA, Exp. Date 2027/01; 4J1V, Exp. Date 2027/09

Recalling companyRohto-Mentholatum (Vietnam) Co., Ltd.

Recall initiated07/14/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Lack of Assurance of Sterility

Distribution: Nationwide within the United States

Class IID-0728-2026

Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01

NDC63323-485-27, 63323-485-01

Lot / batch / code informationLot #: 6130235, Exp. Date 02/2027

Recalling companyFresenius Kabi USA, LLC

Recall initiated07/16/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Presence of Particulate Matter: Hair was found in products

Distribution: Nationwide within in the USA

Class IID-0720-2026

Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, 0.34 FL OZ (10 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011135, NDC 10742-8162-1

NDC10742-8162-1

Lot / batch / code informationLot #: 4G1VA, Exp. Date 2027/06; 4J1VA, Exp. Date 2027/09; 5A1V, Exp. Date 2027/12; 5D1VA, Exp. Date 2028/03; 5G1VA, Exp. Date 2028/06; 512V, 512V, 512VB Exp. Date 2028/08; 5L2VA, 512VB 2028/11.

Recalling companyRohto-Mentholatum (Vietnam) Co., Ltd.

Recall initiated07/14/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Lack of Assurance of Sterility

Distribution: Nationwide within the United States

Class IIID-0736-2026

Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7255-10.

NDC0904-7255-10

Lot / batch / code informationLot: 25141584, Exp 4/30/2027.

Recalling companyAscend Laboratories, LLC

Recall initiated06/30/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

Distribution: USA Nationwide

Class IID-0701-2026

Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61

NDC0904-6950-61

Lot / batch / code informationLot #: N02200, Exp. Date 10/2026

Recalling companyMajor Pharmaceuticals

Recall initiated07/13/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Subpotent Drug

Distribution: Nationwide in the USA.

Class IID-0726-2026

Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-208-05; NDC Vial: 63323-208-01

NDC63323-208-05, 63323-208-01

Lot / batch / code informationLot #: 6133801, Exp. Date 01/2028

Recalling companyFresenius Kabi USA, LLC

Recall initiated07/16/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Presence of Particulate Matter: Hair was found in products

Distribution: Nationwide within in the USA

Class IID-0717-2026

Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%), Sterile, TWIN PACK, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011210, NDC 10742-8158-2

NDC10742-8158-2

Lot / batch / code informationLot #: 3H1V, Exp. Date2026/07; 3J2V, Exp. Date 2026/09; 4A1V, 4A1VA, Exp. Date 2026/12; 4G1V, Exp. Date 2027/06; 4I3V, Exp. Date 2027/08; 5A1V, Exp. Date 2027/12; 5B3V, Exp. Date2028/01; 5G3V, Exp. Date 2028/06; 5J1V, Exp. Date 2028/09; 5L1V, Exp. Date 2028/11; 6A1V, Exp. Date 2028/12; 6B4V, Exp. Date 2029/01; 6C2V, Exp. Date 2029/02.

Recalling companyRohto-Mentholatum (Vietnam) Co., Ltd.

Recall initiated07/14/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Lack of Assurance of Sterility

Distribution: Nationwide within the United States

Class IID-0742-2026

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.

NDC69452-435-30

Lot / batch / code informationLot# 704C003, Exp. 12/31/2028

Recalling companyBionpharma Inc.

Recall initiated06/26/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Presence of Foreign Tablets/Capsules

Distribution: US Nationwide.

Class IIID-0713-2026

Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.

NDC76420-760-01

Lot / batch / code informationLot: 070126X1, Exp. 12/31/2027.

Recalling companyAsclemed USA Inc.

Recall initiated07/15/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Distribution: Within U.S. - Tennessee

Class IID-0712-2026

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30

NDC67877-500-30

Lot / batch / code informationLot 25121311, expiry 3/31/2028

Recalling companyAscend Laboratories, LLC

Recall initiated07/08/2026

StatusOngoing

Recall typeVoluntary: Firm initiated

Reason and distribution details

FDA reason: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

Distribution: Nationwide in the USA

ANIMAL & VETERINARY

Veterinary medication recall reports

0 reports shown

No matching reports in the latest FDA records.

This does not guarantee that no recall exists. Check the official FDA links below.

Always verify through the official FDA record.

FDA recalls and safety alertsFDA animal & veterinary recalls

Source: FDA openFDA Drug Enforcement API. Report dates may differ from the date a recall began.

PARA QUÉ FUE CREADO ESTE SITIO

MediBridge Family fue creado para familias, cuidadores, clínicas, proveedores, hospitales, farmacias y organizaciones que necesitan presentar instrucciones existentes de medicamentos y productos de salud con mayor claridad en español e inglés. Es un servicio de comunicación no clínica.